Revised website and nomenclature

For many years AFFINITI Research Products Ltd and since 1st January 2004 now BIOMOL International LP has maintained a dedicated website/portal for those interested in ubiquitin-proteasome-COP9 signalosome research, namely www.proteasome.com.  The purpose of this dedicated site was to provide users with the most up-to-date product information, nomenclature and technical data, information concerning potential meetings of interest, etc. 

Over recent months this dedicated website has been redesigned and is now launched.  It still has the full breadth and depth of information contained within the previous site but is now fully integrated with the www.biomol.com website.  This integration facilitates online customer and technical support as well as e-commerce possibilities for all our US and UK-based customers.

Visitors to the site may notice the use of two 'new' names, namely 'ubiquitons' and 'zomes'.  Over recent years it has become increasingly difficult to find general terms capable of succinctly describing areas that are becoming increasingly broad.  This applies to 'ubiquitin and ubiquitin-like proteins and their associated cascades' - now coming under the 'ubiquiton' classification.  Similarly 'zomes' is used to categorise the increasing number of multi-subunit, multi-catalytic complexes such as the 11S/PA28, PA200, 19S/PA700, 20S, 26S of proteasomal origin, the COP9 signalosome, the eIF3 complex, the TPPII complex, etc.

Click here to return to the news index.